In situ analysis of tissue dynamics and p53 expression in human gastric mucosa

Journal of Pathology

Volumn 179, Issue 1, 1996, Pages 39-42

  Imatani, Akira ^a   Sasano, Hironobu ^a   Yabuki, Noritaka ^a   Kato, Katsuaki ^a   Ohara, Shuichi ^a   Asaki, Shigeru ^a   Toyota, Takayoshi ^a   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Cell proliferation; Ki67; p53; Stomach

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METAPLASIA; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH MUCOSA;

APOPTOSIS; CELL DIVISION; DNA, NEOPLASM; FEMALE; GASTRIC MUCOSA; HUMANS; KI-67 ANTIGEN; MALE; METAPLASIA; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PARIETAL CELLS, GASTRIC; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029941863     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199605)179:1<39::AID-PATH543>3.0.CO;2-E     Document Type: Article

References (17)

1. Hirota T, Ming S-C. Early gastric carcinoma. In-Ming S-C, Goldman H, eds. Pathology of the Gastrointestinal Tract. Philadelphia W. B Saunders, 1992; 570-583.
2. Jaskiewicz K, Louwrens HD. Chronic atrophic gastritis in a population at risk for gastric carcinoma. Anticancer Res 1991, 11: 835-840.
3. Kato Y, Kitagawa T, Yanagisawa A, et al Site-dependent development of complete and incomplete intestinal metaplasia types in the human stomach Jpn J Cancer Res 1992; 83: 178-183.
4. Gavrieli Y, Sherman Y, Ben-Sasson SA Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992, 119: 493-501
5. Sasano H, Imatani A, Shizawa S, Suzuki T, Nagura H. Cell proliferation and apoptosis in normal pathologic human adrenal Mod Pathol 1995, 8: 11-17.
6. Wallenstein S, Zucker CI, Ferris JL Some statistical methods useful in circulation research Circ Res 1980; 47: 1-26.
7. Sasano H, Goukon Y, Nishihira T, Nagura H In situ hybridization of p53 tumor suppressor gene in human esophageal carcinoma. Am J Pathol 1992, 141: 545-550.
8. Tsutsumi Y, Nagura H, Watanabe K. Immune aspects of intestinal metaplasia of the stomach: an immunohistochemical study. Virchows Arch A [Pathol Anat] 1984; 403: 345-359.
9. Sasano H, Date F, Imitani A, Asaki S, Nagura H. Double immunostaining for c-erb-B2 and p53 in human stomach cancer cells. Hum Pathol 1993 24: 584-589.
10. Shiao Y-H, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alterations in gastric precancerous lesions. Am J Pathol 1994; 144: 511-517.
11. Reich NC, Levine AJ Growth regulation of a cellular tumor antigen, p53. in nontransformed cells. Nature 1984; 308: 199-201.
12. Shaw P, Bovey R, Tardy S, Sahli R, Sardat B. Costa J Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992, 89: 4495-4499.
13. Caelles C, Helmberg A, Karin M p53 dependent apoptosis, in the absence of transcriptional activation of p53 target genes. Nature 1994; 370: 220-223
14. Fritsche M, Haessler C, Brandner G. Induction of nuclear accumulation of the tumor suppressor protein p53 by DNA damaging agents. Oncogene 1993; 8: 307-318.
15. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215-221
16. Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 1994, 9: 1767-1773
17. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992, 52: 6735-6740.